Close Menu

NEW YORK (GenomeWeb) — Clinical Genomics said today that its CLIA-licensed and CAP-accredited New Jersey laboratory has received licensure from California authorities to offer the Colvera colorectal cancer test to residents of the state.

Colvera is a PCR-based test for colorectal cancer recurrence monitoring. It measures methylation in circulating tumor DNA in a peripheral blood sample and can indicate the presence or absence of two altered genes associated with colorectal cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.